Free Trial
NASDAQ:FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

$26.08 +0.45 (+1.74%)
Closing price 03:55 PM Eastern
Extended Trading
$26.08 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Key Stats

Today's Range
$25.77
$26.13
50-Day Range
$24.25
$26.39
52-Week Range
$23.29
$29.72
Volume
2,196 shs
Average Volume
6,657 shs
Market Capitalization
$14.34 million
Assets Under Management
$14.10 million
Dividend Yield
1.69%
Net Expense Ratio
0.60%
Aggregate Rating
Moderate Buy

ETF Overview

First Trust Nasdaq Pharmaceuticals ETF Expenses

TypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.56%0.56%0.54%0.53%
Other Expenses0.00%0.47%0.56%0.52%0.56%
Total Expense0.60%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%
Net Expense0.60%0.60%0.63%0.63%0.60%
Receive FTXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

FTXH ETF News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
Surprising Analyst 12-Month Target For FTXH
Solid Q4 Earnings Fail to Impress Pharma ETFs
See More Headlines

FTXH ETF - Frequently Asked Questions

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.97 at the start of the year. Since then, FTXH stock has decreased by 3.3% and is now trading at $26.0750.
View the best growth stocks for 2025 here
.

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Cannabis Wheaton Income (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC) and Biocorrx (BICX).

Fund Details

Issuer
First Trust
Fund Name
First Trust Nasdaq Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:FTXH
Inception Date
9/20/2016
Fund Manager
Daniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq US Smart Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
50

Fund Statistics

Assets Under Management
$14.10 million
Average Daily Volume
$14.52 thousand
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Old Mission

Options

Optionable
N/A
Short Interest
11,700 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$500.00
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 10 FTXH Holdings

FTXH Sector Exposure

FTXH Industry Exposure


This page (NASDAQ:FTXH) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners